| Financial Year |
March 31 2023 |
| Monetary Funds |
5,387,243,673.76 |
| Held-for-trading Financial Assets |
1,377,756,082.10 |
| Notes Receivable |
-- |
| Accounts Receivable |
429,265,412.38 |
| Advances to Suppliers |
1,011,728,766.26 |
| Other Receivables |
105,742,829.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,501,539,647.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
185,755,463.55 |
| Total Current Assets |
10,503,342,124.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
951,051,661.86 |
| Investment Properties |
-- |
| Fixed Assetes |
4,585,694,447.59 |
| Under-construction Projects |
2,561,874,024.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
483,477,822.86 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,711,461.04 |
| Deferred Income Tax Assets |
131,942,956.64 |
| Other Non-Current Assets |
2,127,883,417.18 |
| Sub-Total of Non-Current Assets |
12,200,875,925.01 |
| Total Assets |
22,704,218,049.21 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,977,208,443.07 |
| Accounts Payable |
1,740,352,742.97 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
88,552,474.02 |
| Taxes Payable |
140,273,963.91 |
| Interest Payable |
-- |
| Dividend Payable |
628,800.00 |
| Other payables |
109,414,360.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
117,271,994.39 |
| Other Current Liabilities |
104,088,141.78 |
| Sub-Total of Current Liabilities |
9,118,486,303.59 |
| Long-term Loans |
85,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
590,038.77 |
| Deferred Income Tax Liabilities |
157,906,302.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
343,632,698.30 |
| Total Liabilities |
9,462,119,001.89 |
| Paid-In Capital(Or Share Stock) |
410,797,479.00 |
| Capital Surplus |
7,064,454,037.05 |
| Surplus Reserve |
205,425,269.50 |
| LESS:Treasury Stock |
78,174,082.42 |
| Undistributed Profits |
5,639,596,344.19 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,242,099,047.32 |
| Owner's Equity（Stockholder's Equity） |
13,242,099,047.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,704,218,049.21 |
